title: Investigation of NK cell function and their modulation in different malignancies.
abstract: NK cells have become a subject of investigation not only in the field of tumor immunology and infectious diseases, but also within all aspects of immunology, such as transplantation, autoimmunity, and hypersensitivity. Our early studies aside from investigating NK cell activity in experimental animals and humans included studies of perforin expression and modulation in this lymphocyte subset. As NK cell activity is modified by their environment, we showed clinical stage-dependent impairment of their activity and in vitro effect of different sera, Th1 cytokines, and their combination in breast cancer, Hodgkin's disease, and non-Hodgkin's lymphoma patients, especially with respect to metabolic and cell membrane changes of peripheral blood lymphocytes evaluated by spontaneous release of the enzyme lactate dehydrogenase (LDH) that led to the correction of the LDH enzyme release assay for natural cytotoxicity. By long-term immuno-monitoring of patients with malignancies, we also showed the kinetics of NK cell modulation during chemo-immunotherapy. In our more recent studies, we give data of NK function and novel families of NK cell receptor expression in healthy individuals that may be of help in NK cell profiling, by giving referent values of basic and cytokine-induced expression of some NK cell receptors either in evaluation of disease or in immuno-monitoring during cytokine therapy of patients with malignancies. Moreover, we give novel aspects of modulation of NK cell activity by cytokines approved for immunotherapy, IFN and IL-2, in melanoma and other malignancies with respect to alterations in new activating (NKG2D and CD161) and inhibitory (CD158a and CD158b) receptor characteristics and signaling molecules in CD16- and CD56-defined NK cells and their small immunoregulatory and large cytotoxic subsets in peripheral blood and lymph nodes, as NK cell-mediated killing of tumor cells depends on the balance between stimulatory and inhibitory signaling.
authors.affiliation: Laboratory for Experimental Immunology, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia. konjevicg@ncrc.ac.rs
authors.forename: Gordana
authors.initials: G
authors.lastname: Konjevic
authors.forename: Vladimir
authors.initials: V
authors.lastname: Jurisic
authors.forename: Viktor
authors.initials: V
authors.lastname: Jovic
authors.forename: Ana
authors.initials: A
authors.lastname: Vuletic
authors.forename: Katarina
authors.initials: K
authors.lastname: Mirjacic Martinovic
authors.forename: Sandra
authors.initials: S
authors.lastname: Radenkovic
authors.forename: Ivan
authors.initials: I
authors.lastname: Spuzic
mesh_terms: D000818:Animals; D016207:Cytokines / Q000096:biosynthesis; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism*; D007770:L-Lactate Dehydrogenase / Q000096:biosynthesis; D008213:Lymphocyte Activation; D051379:Mice; D055651:NK Cell Lectin-Like Receptor Subfamily B / Q000096:biosynthesis; D055655:NK Cell Lectin-Like Receptor Subfamily K / Q000096:biosynthesis; D009369:Neoplasms / Q000276:immunology*; D054353:Perforin / Q000276:immunology / Q000378:metabolism; D054342:Receptors, KIR2DL1 / Q000096:biosynthesis; D054344:Receptors, KIR2DL3 / Q000096:biosynthesis; D018417:Th1 Cells / Q000276:immunology / Q000378:metabolism
chemical_list: D016207:Cytokines; C527085:KLRK1 protein, human; D055651:NK Cell Lectin-Like Receptor Subfamily B; D055655:NK Cell Lectin-Like Receptor Subfamily K; D054342:Receptors, KIR2DL1; D054344:Receptors, KIR2DL3; D054353:Perforin; D007770:L-Lactate Dehydrogenase